Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-26-045778
Filing Date
2026-06-26
Accepted
2026-06-26 16:20:18
Documents
1
Period of Report
2026-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1782505215.html 4  
1 FORM 4 wk-form4_1782505215.xml 4 4050
  Complete submission text file 0001628280-26-045778.txt   5664
Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Business Address
Smith Karen L. (Reporting) CIK: 0001639637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40654 | Film No.: 261129656

Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)